HARVARD BIOSCIENCE INC (HBIO)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 15M 30M 45M Q3 '21: 29.7M Q4 '21: 33.1M Q1 '22: 28.8M Q2 '22: 29.2M Q3 '22: 26.9M Q4 '22: 28.4M Q1 '23: 30M Q2 '23: 28.8M Q3 '23: 25.4M Q4 '23: 28.2M Q1 '24: 24.5M Q2 '24: 23.1M Q3 '24: 22M Q4 '24: 24.6M Q1 '25: 21.8M Q2 '25: 20.4M Q3 '25: 20.6M Q4 '25: 23.7M Q1 '26: 20.8M Q2 '26: 22.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 7M 14M 21M Q3 '21: 16.3M Q4 '21: 19.6M Q1 '22: 16.2M Q2 '22: 16.6M Q3 '22: 12.2M Q4 '22: 15.8M Q1 '23: 18.3M Q2 '23: 16.7M Q3 '23: 14.7M Q4 '23: 16.3M Q1 '24: 14.8M Q2 '24: 13.2M Q3 '24: 12.8M Q4 '24: 14M Q1 '25: 12.2M Q2 '25: 11.5M Q3 '25: 12M Q4 '25: 14.2M Q1 '26: 12.2M Q2 '26: 12.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

-60M -40M -20M 0 20M 40M 60M Q3 '21: 548K Q4 '21: 1.7M Q1 '22: -6.7M Q2 '22: 4M Q3 '22: -3.8M Q4 '22: -457K Q1 '23: 1.7M Q2 '23: 796K Q3 '23: -933K Q4 '23: 282K Q1 '24: -2.3M Q2 '24: -2.1M Q3 '24: -1.9M Q4 '24: 11K Q1 '25: -49.7M Q2 '25: -819K Q3 '25: 197K Q4 '25: 1.7M Q1 '26: -1.2M Q2 '26: -978K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-60M -40M -20M 0 20M 40M 60M Q3 '21: -170K Q4 '21: 961K Q1 '22: -6.9M Q2 '22: 2.4M Q3 '22: -3.4M Q4 '22: -1.7M Q1 '23: 622K Q2 '23: -980K Q3 '23: -1.2M Q4 '23: -1.8M Q1 '24: -4.7M Q2 '24: -2.9M Q3 '24: -4.8M Q4 '24: 18K Q1 '25: -50.3M Q2 '25: -2.3M Q3 '25: -1.2M Q4 '25: -2.8M Q1 '26: -3.4M Q2 '26: -2.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 6M 12M 18M Q3 '21: 13.4M Q4 '21: 13.5M Q1 '22: 12.6M Q2 '22: 12.6M Q3 '22: 14.8M Q4 '22: 12.6M Q1 '23: 11.6M Q2 '23: 12.1M Q3 '23: 10.6M Q4 '23: 11.8M Q1 '24: 9.7M Q2 '24: 9.9M Q3 '24: 9.2M Q4 '24: 10.5M Q1 '25: 9.6M Q2 '25: 8.9M Q3 '25: 8.6M Q4 '25: 9.6M Q1 '26: 8.5M Q2 '26: 10.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-3M -1.5M 0 1.5M 3M 4.5M Q2 '21: 768K Q3 '21: -660K Q4 '21: 117K Q1 '22: -2M Q2 '22: -190K Q3 '22: 649K Q1 '23: 1.8M Q2 '23: 3.6M Q3 '23: 4.4M Q4 '23: 4.3M Q1 '24: 1.4M Q2 '24: -846K Q3 '24: -842K Q4 '24: 1.7M Q1 '25: 3M Q2 '25: 2.8M Q3 '25: 1.1M Q4 '25: -96K Q1 '26: -662K Q2 '26: 325K Q3 '21 Q2 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-3M -1.5M 0 1.5M 3M 4.5M Q2 '21: 562K Q3 '21: -1.1M Q4 '21: -241K Q1 '22: -2.5M Q2 '22: -632K Q3 '22: 207K Q1 '23: 1.6M Q2 '23: 3M Q3 '23: 4.1M Q4 '23: 3.5M Q1 '24: 758K Q2 '24: -1.7M Q3 '24: -1.7M Q4 '24: 1.4M Q1 '25: 2.5M Q2 '25: 2.7M Q3 '25: 877K Q4 '25: -545K Q1 '26: -1.1M Q2 '26: -363K Q3 '21 Q2 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q1 '20: 38.3M Q2 '20: 38.5K Q3 '20: 38.9K Q1 '21: 39.8M Q2 '21: 40.2M Q3 '21: 40.8M Q1 '22: 41.2M Q2 '22: 42.6M Q3 '22: 41.6M Q1 '23: 42.8M Q2 '23: 42.4M Q3 '23: 42.7M Q1 '24: 43.4M Q2 '24: 43.5M Q3 '24: 43.6M Q1 '25: 4.4M Q2 '25: 4.4M Q3 '25: 44.6M Q1 '26: 4.5M Q2 '26: 4.5M Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-15.00 -10.00 -5.00 0.00 5.00 10.00 15.00 Q3 '19: -0.06 Q4 '19: -0.12 Q1 '20: -0.18 Q3 '21: -0.04 Q4 '21: -0.01 Q1 '22: -0.16 Q2 '22: -0.09 Q3 '22: -0.17 Q4 '22: -0.23 Q1 '23: -0.05 Q2 '23: -0.13 Q3 '23: -0.08 Q4 '23: -0.08 Q1 '24: -0.20 Q2 '24: -0.25 Q3 '24: -0.33 Q4 '24: -0.28 Q1 '25: -11.59 Q2 '25: -12.04 Q3 '25: -11.96 Q4 '19 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.